#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2038097	B	Displacement of [3H]PGE2 from mouse EP1 receptor expressed in CHO cells after 20 mins by scintillation counting	Mus musculus	29		cell-based format	Scientific Literature
2.	ALA2038098	B	Displacement of [3H]PGE2 from mouse EP2 receptor expressed in CHO cells after 60 mins by scintillation counting	Mus musculus	29		cell-based format	Scientific Literature
3.	ALA2038099	B	Displacement of [3H]PGE2 from mouse EP3 receptor expressed in CHO cells after 60 mins by scintillation counting	Mus musculus	29		cell-based format	Scientific Literature
4.	ALA2038100	B	Displacement of [3H]PGE2 from mouse EP4 receptor expressed in CHO cells after 60 mins by scintillation counting	Mus musculus	29		cell-based format	Scientific Literature
5.	ALA2038101	F	Agonist activity at rat EP2 receptor expressed in CHO cells assessed as cAMP production after 10 mins by radioimmunoassay	Rattus norvegicus	17		cell-based format	Scientific Literature
6.	ALA2038102	F	Agonist activity at rat EP4 receptor expressed in CHO cells assessed as cAMP production after 10 mins by radioimmunoassay	Rattus norvegicus	29		cell-based format	Scientific Literature
7.	ALA1960455	F	Bone strenthening activity in Sprague-Dawley rat bone fracture-healing model assessed as increase in strength of fractured fibulae bone at 300 ug/kg administered as topical injection with PLGA microsphere formulation for 17 days (Rvb = 56.9 %)	Rattus norvegicus	1		organism-based format	Scientific Literature
8.	ALA1960456	F	Bone strenthening activity in Sprague-Dawley rat bone fracture-healing model assessed as increase in strength of fractured fibulae bone at 1000 ug/kg administered as topical injection with PLGA microsphere formulation for 17 days (Rvb = 56.9 %)	Rattus norvegicus	1		organism-based format	Scientific Literature
9.	ALA1960457	F	Bone strenthening activity in Sprague-Dawley rat bone fracture-healing model assessed as increase in strength of fractured fibulae bone administered as topical injection with PLGA microsphere formulation for 17 days	Rattus norvegicus	1		organism-based format	Scientific Literature
10.	ALA1960458	B	Ratio of EC50 for rat EP4 receptor to Ki for mouse EP4 receptor		4		assay format	Scientific Literature
11.	ALA1960459	B	Ratio of EC50 for rat EP2 receptor to Ki for mouse EP2 receptor		4		assay format	Scientific Literature
12.	ALA1961330	B	Displacement of [3H]-PGE2 from mouse EP1 receptor expressed in CHO cells after 60 mins by scintillation counting	Mus musculus	22		cell-based format	Scientific Literature
13.	ALA1961331	B	Displacement of [3H]-PGE2 from mouse EP2 receptor expressed in CHO cells after 60 mins by scintillation counting	Mus musculus	22		cell-based format	Scientific Literature
14.	ALA1961332	B	Displacement of [3H]-PGE2 from mouse EP3 receptor expressed in CHO cells after 60 mins by scintillation counting	Mus musculus	22		cell-based format	Scientific Literature
15.	ALA1961333	B	Displacement of [3H]-PGE2 from mouse EP4 receptor expressed in CHO cells after 60 mins by scintillation counting	Mus musculus	22		cell-based format	Scientific Literature
16.	ALA1960893	F	Agonist activity at rat EP2 receptor	Rattus norvegicus	8		assay format	Scientific Literature
17.	ALA1960894	F	Agonist activity at rat EP4 receptor	Rattus norvegicus	8		assay format	Scientific Literature
18.	ALA1960895	P	Drug release from PLGA microspheres in PBS buffer assessed as compound remaining at 100 ug/ml after 7 days by HPLC analysis		1		small-molecule physicochemical format	Scientific Literature
19.	ALA1960896	P	Drug release from PLGA microspheres in PBS buffer assessed as compound remaining at 100 ug/ml after 21 days by HPLC analysis		1		small-molecule physicochemical format	Scientific Literature
20.	ALA1960897	P	Drug release from PLGA microspheres in PBS buffer assessed as compound remaining at 100 ug/ml after 28 days by HPLC analysis		1		small-molecule physicochemical format	Scientific Literature